Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of June 2021, with the report dated June 14, 2021. The filing serves to disclose a significant corporate event regarding the Company's board of directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The primary material change disclosed is the passing of Israel Shamay, an external director of the Company, on June 11, 2021. Mr. Shamay had served as an external director since December 2014 and was a member of both the Audit Committee and the Compensation Committee. Prior to his role at Can-Fite, he served as Executive Director, Strategic Initiatives and Head of the Americas Operations of MATIMOP since 2012.
Guidance, Outlook, and Risks
The filing contains no financial guidance, operational outlook, or discussion of risks and contingencies. The document is limited to the announcement of Mr. Shamay's death and the Company's expression of condolences to his family.
Key Facts for Investor Verification
- Israel Shamay, an external director and member of the Audit and Compensation Committees, passed away on June 11, 2021.
- The Company has not announced a replacement for Mr. Shamay in this filing.
- No financial data or operational updates are included in this specific report.